Circular resection of the left main and upper lobe bronchi with bronchoplastyin a patient with central cancer of the lower lobe of the left lung (clinical case)

2025

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.15275/ssmj2103280
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

This clinical case focuses on the complexity of surgical treatment of patient with central non-small cell carcinoma of the left lung. The minimum standard amount of surgical treatment for our patient is a left pneumonectomy with systematic mediastinal lymph dissection due to the spread of the tumor to the distal part of the left main bronchus. Taking into account the young age (47 years old) of patient, in order to improve the quality of life, we performed organ-preserving surgery: lower lobectomy on the left lung with systematic mediastinal lymph dissection, circular resection of the left main bronchus, the left upper lobular bronchus, bronchoplasty with the formation of a circular anastomosis between the left upper lobular and left main bronchus. To prevent the occurrence of bronchopleural fistula, we used a free, unvascularized pleural fat flap from the pericardial part. The postoperative period was uneventful. 30 months after the operation, the patient is observed without tumor recurrence and generalization. Thus, bronchoplastic surgeries make it possible to save the patient more lung parenchyma and improve the quality of life compared to pneumon- and bilobectomies, while remaining a radical method of treating lung cancer, without worsening disease-free survival.